EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical

Globalisation and the Importance of End-to-end Translation Management

Most manufacturers are now global in their outlook as it has become easier than ever for pharmaceutical and medical device companies to market their products all over the world. But global and local regulatory requirements can be complex and varied. Adhering to these is a significant task when registration requires translation of dossier content for each local authority. AMPLEXOR Life Sciences’ Nancy Pollini maps out her vision for what an end-to-end translation programme look like for an international life sciences firm in 2018.

Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18